
AI opportunities in healthcare
ONLINE-ONLY HOTLINK: www.nzoptics.co.nz/articles/archive/digital-people-for-better-healthcare-access

ONLINE-ONLY HOTLINK: www.nzoptics.co.nz/articles/archive/digital-people-for-better-healthcare-access

A New Zealand-developed artificial intelligence (AI) system has been shown to grade advanced age-related macular degeneration (AMD) from retinal images with more than 80% accuracy.

SightGlass Vision has shared positive outcomes of multiple studies evaluating its Diffusion Optics Technology spectacle lenses, designed to slow myopia progression in children. Presenting at the 2023

ONLINE ONLY HOTLINKS: https://www.nzoptics.co.nz/articles/archive/rpe-a-haven-for-ebola/

A Japanese study of 29 adults with pathologic myopia showed 83% already had diffuse atrophy in childhood. Using patient fundus photos taken before they were 15 years old, researchers led by Dr Kyoko Ohno-Matsui, from the Tokyo Medical and Dental University, said category 2 diffuse atrophy, classifie

ONLINE LINK: https://www.nzoptics.co.nz/optometry/dryeyeupdate/

ONLINE LINK: https://www.nzoptics.co.nz/optometry/dryeyeupdate/

US actor and venture capitalist Ashton Kutcher has revealed he suffered from a rare autoimmune disease, vasculitis, impacting his vision, hearing and mobility.

The UK's Association of Optometrists (AOP) has launched a national campaign following a Freedom of Information request revealing at least 200 patients have lost their sight due to NHS backlogs since

ONLINE ONLY HOTLINK: https://pubmed.ncbi.nlm.nih.gov/30513356/

Be My Eyes, a company dedicated to improving accessibility for people who are blind or have low vision, is beta testing its new Virtual Volunteer tool, soon to be integrated into the Be My Eyes

West Australian researchers have developed a breakthrough method to measure the brain fluid pressure in humans, which may reduce vision damage experienced by astronauts on long-haul space flights. A